|
2025-03-12 |
2025-03-11 |
VP
Vente planifiée
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
18 020
-8.4%
23,61
425 510 USD
|
18 020
-8.4%
|
23,61
|
425 510 USD
|
|
|
2025-03-12 |
2025-03-11 |
VP
Vente planifiée
|
Davis John E
Chief Commercial Officer
Dirigeant
|
15 100
-6.7%
23,61
356 549 USD
|
15 100
-6.7%
|
23,61
|
356 549 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
1 048
-0.7%
24,80
25 995 USD
|
1 048
-0.7%
|
24,80
|
25 995 USD
|
|
|
2025-03-10 |
2025-03-06 |
VP
Vente planifiée
|
Mackin James P
President & CEO
Dirigeant
|
70 700
-7.6%
24,76
1 750 843 USD
|
70 700
-7.6%
|
24,76
|
1 750 843 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
17 739
-2.0%
24,80
440 005 USD
|
17 739
-2.0%
|
24,80
|
440 005 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
2 124
-1.1%
24,80
52 685 USD
|
2 124
-1.1%
|
24,80
|
52 685 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
2 618
-1.2%
24,80
64 939 USD
|
2 618
-1.2%
|
24,80
|
64 939 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
1 603
-1.4%
24,80
39 761 USD
|
1 603
-1.4%
|
24,80
|
39 761 USD
|
|
|
2025-03-10 |
2025-03-06 |
V
Vente
|
Berry Lance A
Executive VP, CFO
Dirigeant
|
4 909
-3.1%
24,80
121 764 USD
|
4 909
-3.1%
|
24,80
|
121 764 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
472
-0.3%
25,29
11 935 USD
|
472
-0.3%
|
25,29
|
11 935 USD
|
|
|
2025-03-05 |
2025-03-05 |
A
Achat
|
SEMEDO ANTHONY B.
Administrateur non-exécutif
|
600
+inf%
25,25
15 150 USD
|
600
+inf%
|
25,25
|
15 150 USD
|
|
|
2025-03-05 |
2025-03-05 |
A
Achat
|
SEMEDO ANTHONY B.
Administrateur non-exécutif
|
1 500
+4.4%
25,33
37 991 USD
|
1 500
+4.4%
|
25,33
|
37 991 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
485
-0.4%
27,31
13 243 USD
|
485
-0.4%
|
27,31
|
13 243 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
318
-0.2%
27,31
8 683 USD
|
318
-0.2%
|
27,31
|
8 683 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
814
-0.6%
27,31
22 227 USD
|
814
-0.6%
|
27,31
|
22 227 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
1 706
-1.3%
27,31
46 584 USD
|
1 706
-1.3%
|
27,31
|
46 584 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
4 896
-0.7%
27,31
133 690 USD
|
4 896
-0.7%
|
27,31
|
133 690 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
6 812
-1.0%
27,31
186 008 USD
|
6 812
-1.0%
|
27,31
|
186 008 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
13 784
-2.0%
27,31
376 386 USD
|
13 784
-2.0%
|
27,31
|
376 386 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
16 664
-2.4%
27,31
455 027 USD
|
16 664
-2.4%
|
27,31
|
455 027 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Berry Lance A
Executive VP, CFO
Dirigeant
|
3 259
-4.1%
27,31
88 990 USD
|
3 259
-4.1%
|
27,31
|
88 990 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
1 650
-1.1%
27,31
45 055 USD
|
1 650
-1.1%
|
27,31
|
45 055 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
810
-0.5%
27,31
22 118 USD
|
810
-0.5%
|
27,31
|
22 118 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
490
-0.3%
27,31
13 380 USD
|
490
-0.3%
|
27,31
|
13 380 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
2 385
-1.5%
27,31
65 125 USD
|
2 385
-1.5%
|
27,31
|
65 125 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
2 035
-1.3%
27,31
55 568 USD
|
2 035
-1.3%
|
27,31
|
55 568 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
985
-0.6%
27,31
26 896 USD
|
985
-0.6%
|
27,31
|
26 896 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
591
-0.4%
27,31
16 138 USD
|
591
-0.4%
|
27,31
|
16 138 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
2 846
-1.7%
27,31
77 713 USD
|
2 846
-1.7%
|
27,31
|
77 713 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
1 246
-1.5%
27,31
34 023 USD
|
1 246
-1.5%
|
27,31
|
34 023 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
672
-0.8%
27,31
18 350 USD
|
672
-0.8%
|
27,31
|
18 350 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
470
-0.6%
27,31
12 834 USD
|
470
-0.6%
|
27,31
|
12 834 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
2 299
-2.7%
27,31
62 776 USD
|
2 299
-2.7%
|
27,31
|
62 776 USD
|
|
|
2024-12-12 |
2024-12-11 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
4 035
-2.6%
30,00
121 050 USD
|
4 035
-2.6%
|
30,00
|
121 050 USD
|
|
|
2024-12-12 |
2024-12-11 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
4 035
-2.5%
30,25
122 059 USD
|
4 035
-2.5%
|
30,25
|
122 059 USD
|
|
|
2024-12-09 |
2024-12-06 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
4 329
-3.1%
29,66
128 398 USD
|
4 329
-3.1%
|
29,66
|
128 398 USD
|
|
|
2024-12-04 |
2024-12-04 |
VP
Vente planifiée
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
7 618
-18.5%
30,00
228 540 USD
|
7 618
-18.5%
|
30,00
|
228 540 USD
|
|
|
2024-10-02 |
2024-10-01 |
VP
Vente planifiée
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
12 430
-8.2%
26,18
325 415 USD
|
12 430
-8.2%
|
26,18
|
325 415 USD
|
|
|
2024-08-27 |
2024-08-26 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
3 167
-1.9%
26,55
84 096 USD
|
3 167
-1.9%
|
26,55
|
84 096 USD
|
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Getz Matthew A
VP, Human Resources
Dirigeant
|
2 562
-7.0%
25,31
64 848 USD
|
2 562
-7.0%
|
25,31
|
64 848 USD
|
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Getz Matthew A
VP, Human Resources
Dirigeant
|
6 858
-15.8%
25,31
173 586 USD
|
6 858
-15.8%
|
25,31
|
173 586 USD
|
|
|
2024-08-16 |
2024-08-15 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
2 383
-1.4%
25,76
61 393 USD
|
2 383
-1.4%
|
25,76
|
61 393 USD
|
|
|
2024-08-15 |
2024-08-13 |
V
Vente
|
SEMEDO ANTHONY B.
Administrateur non-exécutif
|
9 709
-22.1%
24,99
242 628 USD
|
9 709
-22.1%
|
24,99
|
242 628 USD
|
|
|
2024-05-13 |
2024-05-10 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
1 250
-0.7%
23,42
29 275 USD
|
1 250
-0.7%
|
23,42
|
29 275 USD
|
|
|
2024-05-10 |
2024-05-09 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
979
-0.6%
23,79
23 286 USD
|
979
-0.6%
|
23,79
|
23 286 USD
|
|
|
2024-05-10 |
2024-05-09 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
979
-0.6%
23,79
23 286 USD
|
979
-0.6%
|
23,79
|
23 286 USD
|
|
|
2024-03-21 |
2024-03-20 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
2 183
-2.6%
20,39
44 511 USD
|
2 183
-2.6%
|
20,39
|
44 511 USD
|
|
|
2024-03-18 |
2024-03-15 |
VP
Vente planifiée
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
1 462
-3.4%
20,00
29 240 USD
|
1 462
-3.4%
|
20,00
|
29 240 USD
|
|
|
2024-03-15 |
2024-03-14 |
VP
Vente planifiée
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
3 994
-8.6%
20,00
79 880 USD
|
3 994
-8.6%
|
20,00
|
79 880 USD
|
|
|
2024-03-14 |
2024-03-12 |
V
Vente
|
Getz Matthew A
VP, Human Resources
Dirigeant
|
5 000
-10.3%
19,94
99 720 USD
|
5 000
-10.3%
|
19,94
|
99 720 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Getz Matthew A
VP, Human Resources
Dirigeant
|
1 157
-2.3%
18,72
21 661 USD
|
1 157
-2.3%
|
18,72
|
21 661 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Maney Rochelle L.
VP, Quality
Dirigeant
|
1 157
-2.4%
18,72
21 662 USD
|
1 157
-2.4%
|
18,72
|
21 662 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
1 506
-1.7%
18,72
28 195 USD
|
1 506
-1.7%
|
18,72
|
28 195 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
2 380
-1.4%
18,72
44 559 USD
|
2 380
-1.4%
|
18,72
|
44 559 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
13 996
-1.9%
18,72
262 037 USD
|
13 996
-1.9%
|
18,72
|
262 037 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
2 022
-1.2%
18,72
37 856 USD
|
2 022
-1.2%
|
18,72
|
37 856 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
1 152
-0.8%
18,72
21 568 USD
|
1 152
-0.8%
|
18,72
|
21 568 USD
|
|
|
2024-03-07 |
2024-03-05 |
V
Vente
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
1 160
-2.4%
18,72
21 718 USD
|
1 160
-2.4%
|
18,72
|
21 718 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
465
-0.6%
19,83
9 223 USD
|
465
-0.6%
|
19,83
|
9 223 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Horton Amy
VP, Chief Accounting Officer
Dirigeant
|
325
-0.2%
19,83
6 446 USD
|
325
-0.2%
|
19,83
|
6 446 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Holloway Jean F
SVP, General Counsel
Dirigeant
|
485
-0.3%
19,83
9 620 USD
|
485
-0.3%
|
19,83
|
9 620 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Tyrs Florian
VP, Global Operations
Dirigeant
|
339
-1.5%
19,83
6 724 USD
|
339
-1.5%
|
19,83
|
6 724 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
4 837
-0.7%
19,83
95 939 USD
|
4 837
-0.7%
|
19,83
|
95 939 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Getz Matthew A
VP, Human Resources
Dirigeant
|
325
-0.7%
19,83
6 446 USD
|
325
-0.7%
|
19,83
|
6 446 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Maney Rochelle L.
VP, Quality
Dirigeant
|
370
-0.8%
19,83
7 339 USD
|
370
-0.8%
|
19,83
|
7 339 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
Davis John E
Chief Commercial Officer
Dirigeant
|
584
-0.4%
19,83
11 583 USD
|
584
-0.4%
|
19,83
|
11 583 USD
|
|
|
2024-02-29 |
2024-02-27 |
V
Vente
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
421
-0.9%
19,83
8 350 USD
|
421
-0.9%
|
19,83
|
8 350 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
1 448
-1.7%
20,27
29 353 USD
|
1 448
-1.7%
|
20,27
|
29 353 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Dirigeant
|
1 600
-2.2%
20,27
32 434 USD
|
1 600
-2.2%
|
20,27
|
32 434 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
1 218
-2.7%
20,27
24 690 USD
|
1 218
-2.7%
|
20,27
|
24 690 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
GREEN ANDREW M
VP Regulatory
Dirigeant
|
1 185
-3.0%
20,27
24 021 USD
|
1 185
-3.0%
|
20,27
|
24 021 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Maney Rochelle L.
VP, Quality
Dirigeant
|
1 130
-2.5%
20,27
22 906 USD
|
1 130
-2.5%
|
20,27
|
22 906 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Maney Rochelle L.
VP, Quality
Dirigeant
|
1 185
-2.9%
20,27
24 021 USD
|
1 185
-2.9%
|
20,27
|
24 021 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
13 168
-1.9%
20,27
266 930 USD
|
13 168
-1.9%
|
20,27
|
266 930 USD
|
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Mackin James P
President & CEO
Dirigeant
|
18 144
-2.7%
20,27
367 799 USD
|
18 144
-2.7%
|
20,27
|
367 799 USD
|
|
